Oncolytics Biotech Inc

ONCY USD0.001
Create an alert
Sell$0.79
Buy$0.82
$0.00 (0.24%)
Last updated today at 03:42 UTC

Key metrics

Open$0.80
Previous close$0.80
Market cap$95.15m
P/E ratio-
Volume571,291
Dividend yield0.00%
EMS-

Oncolytics Biotech Inc. is a clinical-stage biotechnology company developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense ...

  • LocationCanada
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyUSD
  • Shares in issue119.35m

Take a closer look at this company’s financial statements and dividend information.

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.